Whistleblowers Appeal Dismissal Of Novartis FCA Xolair Suit
Whistleblowers who accused Novartis Pharmaceuticals Corp. and Genentech Inc. of off-label marketing and providing kickbacks to sell an asthma drug are appealing a Massachusetts federal judge's dismissal of their False Claims...To view the full article, register now.
Already a subscriber? Click here to view full article